Product complaint # (b)(4).Event date is unknown.Reporter is a j&j sales representative.Investigation flow: visual.Visual inspection: the rod cutter 3.5 and 4.0 rods (part #: 202000135 / lot #: gs676414) was received at us cq.Upon visual inspection, foreign substance was identified on the device on the cutting edge which could be blood stains and can be removed on cleaning.No other issues were identified with the device.Document/specification review: drawing(s) reviewed: (current & manufactured revisions).Dimensional inspection: dimensional inspection was not performed due to a definitive finding of rust on the device.Conclusion: the complaint was not confirmed for the received crod cutter 3.5 and 4.0 rods (part #: 202000135 / lot #: gs676414) as no discoloration or fading was observed.However, foreign substance (could be blood stains) was identified was found on the device.Although no definitive root-cause can be determined its possible that maintenance of the device could have contributed to this condition.There was no indication that a design or manufacturing issue contributed to the complaint.No design issues were observed during the document/specification review.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Device history lot a review of the receiving inspection (ri) for rod cutter 3.5 and 4.0 rods was conducted identifying that lot number gs676414 was released in two batches: batch 1: lot qty of (b)(4) units were released on apr 17, 2020 with no discrepancies.Batch 2: lot qty of (b)(4) units were released on oct 12, 2020 with no discrepancies.As a result, the ri identified no issues during the manufacturing and release of this device that could have contributed to the problem reported by the customer.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|